| Abstrakt: |
Tempus Labs has been issued a patent for a method and process for predicting and analyzing patient cohort response, progression, and survival. The patent describes a system and user interface that uses a pre-existing dataset to predict the expected response of a particular patient population or cohort when provided with a certain treatment. The system analyzes patterns in patient clinical, molecular, phenotypic, and response data to facilitate the discovery of therapeutic insights. The patent also includes methods for identifying outlier groups of patients and implementing prediction models. The inventors of the patent are Caroline Epstein, Carin Fishel Queen, Julian Habib, Ashraf Hafez, and Hailey Lefkofsky. [Extracted from the article] |
